These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Barr LF; Kolodner K Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903 [TBL] [Abstract][Full Text] [Related]
7. Non-dialysis-dependent renal dysfunction and cardiac surgery-an assessment of perioperative risk factors. Kowdley GC; Maithal S; Ahmed S; Naftel D; Karp R Curr Surg; 2005; 62(1):64-70. PubMed ID: 15708149 [TBL] [Abstract][Full Text] [Related]
8. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ranucci M; Soro G; Barzaghi N; Locatelli A; Giordano G; Vavassori A; Manzato A; Melchiorri C; Bove T; Juliano G; Uslenghi MF Ann Thorac Surg; 2004 Oct; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494 [TBL] [Abstract][Full Text] [Related]
9. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. Roasio A; Lobreglio R; Santin A; Landoni G; Verdecchia C J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):23-6. PubMed ID: 18249326 [TBL] [Abstract][Full Text] [Related]
11. Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent. Samuels J; Finkel K; Gubert M; Johnson T; Shaw A Ren Fail; 2005; 27(1):101-5. PubMed ID: 15717642 [TBL] [Abstract][Full Text] [Related]
12. Different profiles of patients who require dialysis after cardiac surgery. Gaudino M; Luciani N; Giungi S; Caradonna E; Nasso G; Schiavello R; Luciani G; Possati G Ann Thorac Surg; 2005 Mar; 79(3):825-9; author reply 829-30. PubMed ID: 15734386 [TBL] [Abstract][Full Text] [Related]
13. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. Cogliati AA; Vellutini R; Nardini A; Urovi S; Hamdan M; Landoni G; Guelfi P J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):847-50. PubMed ID: 18068064 [TBL] [Abstract][Full Text] [Related]
14. Effect of risk-adjusted, non-dialysis-dependent renal dysfunction on mortality and morbidity following coronary artery bypass surgery: a multi-centre study. Devbhandari MP; Duncan AJ; Grayson AD; Fabri BM; Keenan DJ; Bridgewater B; Jones MT; Au J; Eur J Cardiothorac Surg; 2006 Jun; 29(6):964-70. PubMed ID: 16675230 [TBL] [Abstract][Full Text] [Related]
15. Logistic risk model predicting postoperative renal failure requiring dialysis in cardiac surgery patients. Rahmanian PB; Kwiecien G; Langebartels G; Madershahian N; Wittwer T; Wahlers T Eur J Cardiothorac Surg; 2011 Sep; 40(3):701-7. PubMed ID: 21334918 [TBL] [Abstract][Full Text] [Related]
16. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Haase M; Haase-Fielitz A; Bagshaw SM; Reade MC; Morgera S; Seevenayagam S; Matalanis G; Buxton B; Doolan L; Bellomo R Crit Care Med; 2007 May; 35(5):1324-31. PubMed ID: 17414730 [TBL] [Abstract][Full Text] [Related]
18. Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors. Del Duca D; Iqbal S; Rahme E; Goldberg P; de Varennes B Ann Thorac Surg; 2007 Oct; 84(4):1264-71. PubMed ID: 17888981 [TBL] [Abstract][Full Text] [Related]
19. Renal dysfunction after cardiac surgery. Abrahamov D; Tamariz M; Fremes S; Tobe S; Christakis G; Guru V; Sever J; Goldman B Can J Cardiol; 2001 May; 17(5):565-70. PubMed ID: 11381278 [TBL] [Abstract][Full Text] [Related]
20. The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass. Adluri RK; Singh AV; Skoyles J; Robins A; Hitch A; Baker M; Mitchell IM Eur J Cardiothorac Surg; 2009 Jun; 35(6):988-94. PubMed ID: 19406658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]